Purple Biotech Ltd ADR
(PPBT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,592 | 4,736 | 5,772 | 7,401 | 5,438 |
| Marketable Securities | 862 | 1,183 | 1,315 | 1,123 | 862 |
| Other current assets | 320 | 394 | 428 | 384 | 638 |
| TOTAL | $10,774 | $6,313 | $7,515 | $8,908 | $6,938 |
| Non-Current Assets | |||||
| PPE Net | 122 | 135 | 111 | 124 | 123 |
| Intangibles | 27,842 | 27,842 | 27,842 | 27,842 | 27,842 |
| Other Non-Current Assets | 323 | 88 | 126 | 164 | 202 |
| TOTAL | $28,287 | $28,065 | $28,079 | $28,130 | $28,167 |
| Total Assets | $39,061 | $34,378 | $35,594 | $37,038 | $35,105 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,778 | 1,819 | 2,210 | 2,655 | 3,715 |
| Other current liabilities | 4,072 | 267 | 411 | 1,149 | 1,560 |
| TOTAL | $6,057 | $2,189 | $2,758 | $3,987 | $5,459 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 191 | 144 | 143 | 145 | 184 |
| TOTAL | $189 | $140 | $140 | $140 | $179 |
| Total Liabilities | $6,246 | $2,329 | $2,898 | $4,127 | $5,638 |
| Shareholders' Equity | |||||
| Retained earnings | -147,534 | -146,231 | -145,146 | -144,693 | -144,283 |
| Other shareholders' equity | 28,519 | 28,457 | 29,905 | 29,973 | 30,103 |
| TOTAL | $32,815 | $32,049 | $32,696 | $32,911 | $29,467 |
| Total Liabilities And Equity | $39,061 | $34,378 | $35,594 | $37,038 | $35,105 |